TIM-3 therapy for Alzheimer’s is garnering attention as a promising approach to combating Alzheimer's disease by harnessing immune system mechanisms traditionally exploited in cancer treatment.Recent studies reveal that blocking the TIM-3 checkpoint molecule can unleash microglia, the brain's resident immune cells, allowing them to effectively clear amyloid plaques, which are hallmarks of Alzheimer’s.